Clinical Trial Update: E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update involving E-B-FAHF-2, Multi OIT, and Xolair (Omalizumab) for food allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• E-B-FAHF-2
• Multi OIT
• Xolair (omalizumab)

Snippet

Sponsor: Xiu-Min Li | Conditions: Food Allergy | Phase 2 | Status: UNKNOWN